No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

Ítems similars

• Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
  per: Vassal, G., et al.
  Publicat: (1996)
• Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
  per: Geoerger, B, et al.
  Publicat: (2003)
• Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
  per: Boland, I, et al.
  Publicat: (1999)
• In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of Micronuclei
  per: Valent, Alexander, et al.
  Publicat: (2001)
• Activity of irinotecan and temozolomide in the presence of O(6)-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
  per: Cai, W, et al.
  Publicat: (2010)